4.4 Review

Systematic Review of Design and Effects of Splints and Exercise Programs in Hand Osteoarthritis

Journal

ARTHRITIS CARE & RESEARCH
Volume 63, Issue 6, Pages 834-848

Publisher

WILEY
DOI: 10.1002/acr.20427

Keywords

-

Categories

Ask authors/readers for more resources

Objective. To describe and evaluate the design and effects of splints and exercise programs in hand osteoarthritis. Methods. Controlled trials identified through systematic literature reviews were included. Design of splints and exercise programs were evaluated according to existing recommendations and classification systems. The risk of bias was assessed by 2 independent reviewers and effects were summarized descriptively or by meta-analyses. Results. Twelve trials were included in the review: 7 assessed the effect of splints, 3 the effect of exercises, and 2 a combination of splints and exercises. The results revealed a great variety in the design of splint and exercise programs. A meta-analysis of the 2 randomized trials with low risk of bias demonstrated that splints significantly reduced hand pain at short-term (<3 months) and long-term (>= 3 months) followup, with a standardized mean difference of 0.37 (95% confidence interval [95% CI] 0.03, 0.71) and 0.80 (95% CI 0.45, 1.15), respectively. Further, results from single trials indicated that hand exercises may reduce pain and increase range of motion and strength, while a combination of splints and daily exercises may reduce pain and stiffness and improve function. Conclusion. There is consistent evidence that splints reduce hand pain, but limited evidence for the effects of hand exercises and a combination of hand exercises and splints in hand osteoarthritis.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Rheumatology

Fatigue in patients with early rheumatoid arthritis undergoing treat-to-target therapy: predictors and response to treatment

Karen Holten, Nina Paulshus Sundlisater, Siri Lillegraven, Joseph Sexton, Lena Bugge Nordberg, Ellen Moholt, Hilde Berner Hammer, Till Uhlig, Tore K. Kvien, Espen A. Haavardsholm, Anna-Birgitte Aga

Summary: Fatigue is a common symptom in early RA patients, with a rapid and sustained reduction during treatment. Low objective disease activity and high patient global assessment at baseline were predictors of clinically relevant fatigue at 24 months.

ANNALS OF THE RHEUMATIC DISEASES (2022)

Article Rheumatology

Serious infections in patients with rheumatoid arthritis and psoriatic arthritis treated with tumour necrosis factor inhibitors: data from register linkage of the NOR-DMARD study

Ingrid Egeland Christensen, Siri Lillegraven, Pawel Mielnik, Gunnstein Bakland, Liz Loli, Joe Sexton, Till Uhlig, Tore K. Kvien, Sella A. Provan

Summary: The study estimated the incidence of serious infections (SIs) in patients with rheumatoid arthritis (RA) and psoriatic arthritis (PsA) treated with TNFi, and compared the risk of SIs between the two groups. The results showed that patients with PsA had a lower risk of SIs compared to those with RA during TNFi treatment.

ANNALS OF THE RHEUMATIC DISEASES (2022)

Article Rheumatology

Associations between joint pathologies and central sensitization in persons with hand osteoarthritis: results from the Nor-Hand study

Pernille Steen Pettersen, Tuhina Neogi, Karin Magnusson, Alexander Mathiessen, Hilde Berner Hammer, Till Uhlig, Tore K. Kvien, Ida K. Haugen

Summary: The pathologies and symptom duration of hand osteoarthritis (OA) are related to central sensitization, with erosive hand OA potentially causing greater central sensitization. Structural and inflammatory severity are not associated with central sensitization, while symptom duration does not contribute to central sensitization.

RHEUMATOLOGY (2022)

Article Rheumatology

Inflammation and biologic therapy in patients with rheumatoid arthritis achieving versus not achieving ACR/EULAR Boolean remission in a treat-to-target study

Nina Paulshus Sundlisaeter, Ulf Sundin, Anna-Birgitte Aga, Joseph Sexton, Hilde Berner Hammer, Till Uhlig, Tore K. Kvien, Espen A. Haavardsholm, Siri Lillegraven

Summary: This study investigated the limiting factors of achieving ACR/EULAR Boolean remission in rheumatoid arthritis (RA) patients. Patient global assessment and tender joints were found to be the most common factors limiting remission. Although imaging inflammation levels were not elevated in patients failing to meet the criteria, the odds of using biologic disease modifying anti-rheumatic drugs (DMARDs) were higher.

RMD OPEN (2022)

Article Rheumatology

2021 EULAR recommendations regarding lifestyle behaviours and work participation to prevent progression of rheumatic and musculoskeletal diseases

James M. Gwinnutt, Maud Wieczorek, Andra Balanescu, Heike A. Bischoff-Ferrari, Annelies Boonen, Giulio Cavalli, Savia de Souza, Annette de Thurah, Thomas E. Dorner, Rikke Helene Moe, Polina Putrik, Javier Rodriguez-Carrio, Lucia Silva-Fernandez, Tanja Stamm, Karen Walker-Bone, Joep Welling, Mirjana Zlatkovic-Svenda, Francis Guillemin, Suzanne M. M. Verstappen

Summary: A taskforce in Europe has reviewed the literature and developed recommendations on lifestyle behaviors for rheumatic and musculoskeletal diseases. They have identified five overarching principles and 18 specific recommendations based on available evidence. The recommendations cover various lifestyle factors such as exercise, diet, weight, alcohol, smoking, and work participation.

ANNALS OF THE RHEUMATIC DISEASES (2023)

Review Rheumatology

Effects of physical exercise and body weight on disease-specific outcomes of people with rheumatic and musculoskeletal diseases (RMDs): systematic reviews and meta-analyses informing the 2021 EULAR recommendations for lifestyle improvements in people with RMDs

James M. Gwinnutt, Maud Wieczorek, Giulio Cavalli, Andra Balanescu, Heike A. Bischoff-Ferrari, Annelies Boonen, Savia de Souza, Annette de Thurah, Thomas E. Dorner, Rikke Helene Moe, Polina Putrik, Javier Rodriguez-Carrio, Lucia Silva-Fernandez, Tanja Stamm, Karen Walker-Bone, Joep Welling, Mirjana Zlatkovic-Svenda, Francis Guillemin, Suzanne M. M. Verstappen

Summary: This paper reviews the effects of physical exercise and body weight on disease-specific outcomes in people with RMDs. Exercise interventions can result in improvements in pain and function, while increased body weight is associated with worse outcomes.

RMD OPEN (2022)

Article Rheumatology

Urate crystal deposition is associated with inflammatory markers and carotid artery pathology in patients with intercritical gout: results from the NOR-Gout study

Hilde Berner Hammer, Silvia Rollefstad, Anne Grete Semb, Gro Jensen, Lars Fridtjof Karoliussen, L. Terslev, Espen A. Haavardsholm, Tore K. Kvien, Till Uhlig

Summary: The study found that crystal deposition in gout patients is associated with increased inflammation levels and carotid artery pathology, suggesting that crystal deposition may lead to subclinical inflammation with subsequent vascular implications. However, further longitudinal studies are needed to confirm these causal relationships.

RMD OPEN (2022)

Article Rheumatology

Fluctuation and change of serum urate levels and flares in gout: results from the NOR-Gout study

T. Uhlig, L. F. Karoliussen, J. Sexton, T. K. Kvien, E. A. Haavardsholm, F. Perez-Ruiz, H. B. Hammer

Summary: This study investigates the relationship between fluctuation and change in serum urate (SU) levels and the occurrence of gout flares. The results show that fluctuations and changes in SU levels are related to gout flares, while changes between visits and reaching higher SU levels are not.

CLINICAL RHEUMATOLOGY (2022)

Article Rheumatology

Changes in Tophus Composition During Urate-Lowering Therapy: A Dual-Energy Computed Tomography Study

Leanne Chen, Gregory D. Gamble, Anne Horne, Jill Drake, Anthony J. Doyle, Till Uhlig, Lisa K. Stamp, Nicola Dalbeth

Summary: This study finds that the composition of the gouty tophus changes during urate-lowering therapy, with a decrease in the urate volume and a relatively slower decrease in the soft tissue volume, which may persist.

ARTHRITIS CARE & RESEARCH (2023)

Article Rheumatology

Course and predictors of work productivity in gout - results from the NOR-Gout longitudinal 2-year treat-to-target study

Till Uhlig, Lars F. Karoliussen, Joe Sexton, Sella Aarrestad Provan, Tore K. Kvien, Espen A. Haavardsholm, Hilde Berner Hammer

Summary: This study explored the longitudinal changes and predictors of work productivity in patients with gout. The results showed that work productivity and activity impairment improved during the first few months of treatment and remained stable at 1 and 2 years. Comorbidities and concerns about medication were associated with worse work impairment and activity impairment.

RHEUMATOLOGY (2023)

Article Rheumatology

Beliefs about medicines in gout patients: results from the NOR-Gout 2-year study

T. Uhlig, L. F. Karoliussen, J. Sexton, T. K. Kvien, E. A. Haavardsholm, W. J. Taylor, H. B. Hammer

Summary: This longitudinal study aimed to determine changes in beliefs about medicines during intervention with urate-lowering therapy (ULT). The study found that patients taking ULT gradually increased their beliefs in the necessity of medication and reduced concerns, but this improvement was unrelated to treatment outcomes.

SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2023)

Article Medicine, General & Internal

Work Ability in the Year after Rehabilitation-Results from the RehabNytte Cohort

Mari Nilsen Skinnes, Rikke Helene Moe, Thomas Johansen, Peter Solvoll Lyby, Kjersti Dahl, Idun Eid, Tor Christian Fagertun, Andreas Habberstad, Tonje Jossie Johnsen, Ingvild Kjeken, Mari Klokkerud, Anita Dyb Linge, Anne Dorte Lyken, Anders Orpana, Tarja Rajalahti, Ross Wilkie, Till Uhlig

Summary: The study found that a multidisciplinary rehabilitation program led to a significant increase in work ability. High self-perceived health was associated with higher work ability at 12 months, while being married or cohabiting, having more comorbidities, and experiencing medium baseline pain intensity were associated with lower work ability. There were no significant differences in work ability between participants receiving occupational and standard rehabilitation.

JOURNAL OF CLINICAL MEDICINE (2023)

Review Rheumatology

Sarcoidosis with musculoskeletal manifestations: systematic review of non-pharmacological and pharmacological treatments

Geir Smedslund, Annie Martina Kotar, Till Uhlig

Summary: This study aimed to summarize the effects and usage of non-pharmacological and pharmacological treatments for sarcoidosis with musculoskeletal manifestations. The study identified 11 relevant studies, but none had a control group. Results showed a high proportion of patients received corticosteroids, NSAIDs, and other pharmacological treatments, while the use of non-pharmacological treatments was minimal. The study highlights the need for further research, particularly randomized clinical trials, to evaluate the treatment effects for sarcoidosis patients with musculoskeletal manifestations.

RHEUMATOLOGY INTERNATIONAL (2022)

Article Rheumatology

One- and 2-year flare rates after treat-to-target and tight-control therapy of gout: results from the NOR-Gout study

Till Uhlig, Lars F. Karoliussen, Joe Sexton, Tore K. Kvien, Espen A. Haavardsholm, Fernando Perez-Ruiz, Hilde Berner Hammer

Summary: The study found that gout flares were frequent in patients undergoing a treat-to-target urate-lowering therapy strategy, especially in the first year and months 3-6, but were much less frequent in the second year. Baseline crystal depositions were important predictors of flares over 2 years, supporting early initiation of urate-lowering therapy in the disease course.

ARTHRITIS RESEARCH & THERAPY (2022)

No Data Available